↓ Skip to main content

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures

Overview of attention for article published in Trials, August 2021
Altmetric Badge

Mentioned by

twitter
7 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
Published in
Trials, August 2021
DOI 10.1186/s13063-021-05457-5
Pubmed ID
Authors

Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, Kate Hayes, Anne Verbrugge, Hettie M. Janssens, Nadine Dufeu, Nicholas J. Simmonds, Lieven J. Dupont, Damian G. Downey

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 15%
Student > Bachelor 2 10%
Student > Master 2 10%
Other 1 5%
Lecturer > Senior Lecturer 1 5%
Other 1 5%
Unknown 10 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 15%
Chemical Engineering 1 5%
Veterinary Science and Veterinary Medicine 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Nursing and Health Professions 1 5%
Other 3 15%
Unknown 10 50%